IL123220A0 - Ibogamine congeners - Google Patents

Ibogamine congeners

Info

Publication number
IL123220A0
IL123220A0 IL12322096A IL12322096A IL123220A0 IL 123220 A0 IL123220 A0 IL 123220A0 IL 12322096 A IL12322096 A IL 12322096A IL 12322096 A IL12322096 A IL 12322096A IL 123220 A0 IL123220 A0 IL 123220A0
Authority
IL
Israel
Prior art keywords
substituted alkyl
unsubstituted
group
alkyl
nhr8
Prior art date
Application number
IL12322096A
Other languages
English (en)
Original Assignee
Albany Medical College
Univ Vermont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albany Medical College, Univ Vermont filed Critical Albany Medical College
Publication of IL123220A0 publication Critical patent/IL123220A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Glass Compositions (AREA)
  • Executing Machine-Instructions (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
IL12322096A 1995-08-08 1996-08-02 Ibogamine congeners IL123220A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US204895P 1995-08-08 1995-08-08
PCT/US1996/012627 WO1997005869A1 (en) 1995-08-08 1996-08-02 Ibogamine congeners

Publications (1)

Publication Number Publication Date
IL123220A0 true IL123220A0 (en) 1998-09-24

Family

ID=21699020

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12322096A IL123220A0 (en) 1995-08-08 1996-08-02 Ibogamine congeners

Country Status (6)

Country Link
US (1) US6211360B1 (de)
EP (1) EP0859610B1 (de)
AT (1) ATE315389T1 (de)
DE (1) DE69635737D1 (de)
IL (1) IL123220A0 (de)
WO (1) WO1997005869A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780871B2 (en) 2001-01-29 2004-08-24 Albany Medical College Methods and compositions for treating addiction disorders
BR0106261A (pt) * 2001-12-26 2003-09-02 Fundacao Oswaldo Cruz Composições medicamentosas contendo alcalóides indólicos para o tratamento da aids
US20030199496A1 (en) * 2002-04-22 2003-10-23 Simon David Lew Pharmaceutical compositions containing alpha3beta4 nicotinic receptor antagonists and methods of their use
US20050251442A1 (en) * 2004-05-07 2005-11-10 Joseph Ficalora Consumer incentive system and business method
US8993559B2 (en) * 2008-01-28 2015-03-31 Albany Medical College Use of ibogamine congeners for treating obesity
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
RU2586296C2 (ru) * 2010-07-23 2016-06-10 Демеркс, Инк. Композиции норибогаина
EP2481740B1 (de) * 2011-01-26 2015-11-04 DemeRx, Inc. Verfahren und Zusammensetzungen zur Herstellung von Noribogain aus Voacangin
US8742096B2 (en) * 2011-03-28 2014-06-03 Demerx, Inc. Methods and compositions for preparing noribogaine from voacangine
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
EP2788003A4 (de) 2011-12-09 2015-05-27 Demerx Inc Phosphatester von noribogain
JP2015509075A (ja) 2011-12-09 2015-03-26 デメレックス， インコーポレイテッド ノルイボガインの硫酸エステル
US20130178618A1 (en) 2012-01-10 2013-07-11 William Allen Boulanger Novel pharmaceutical intermediates and methods for preparing the same
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
EP2807168A4 (de) 2012-01-25 2015-10-14 Demerx Inc Synthetisches voacangin
US20150051192A1 (en) * 2012-03-27 2015-02-19 Albany Medical College Blocking of cue-induced drug reinstatement
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
CA2896133A1 (en) 2012-12-20 2014-06-26 Demerx, Inc. Substituted noribogaine
EP2948188B1 (de) 2013-01-24 2021-09-08 Tylerton International Holdings Inc. Neuronale bildgebung und behandlung
JP6334566B2 (ja) 2013-01-24 2018-05-30 タイラートン インターナショナル ホールディングス インコーポレイテッドＴｙｌｅｒｔｏｎ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｈｏｌｄｉｎｇｓ Ｉｎｃ． 身体構造イメージング
EP3041569A4 (de) 2013-09-08 2017-07-19 Tylerton International Inc. Erkennung von herzzonen mit reduzierter kontrolle
CN106102583A (zh) 2014-01-10 2016-11-09 泰勒顿国际公司 瘢痕和纤维心脏区的检测
US9550789B2 (en) 2014-06-18 2017-01-24 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
US10776961B2 (en) 2014-07-30 2020-09-15 Navix International Limited Registering nuclear medicine data
US20230102206A1 (en) * 2020-03-05 2023-03-30 The Trustees Of Columbia University In The City Of New York Ibogaine analogs as therapeutics for neurological and psychiatric disorders
US11680066B2 (en) * 2020-05-18 2023-06-20 Jeffrey Alan McKinney Ibogaine-related compounds and corresponding methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH434281A (de) * 1964-03-04 1967-04-30 Geigy Ag J R Verfahren zur Herstellung von polycyclischen Indolderivaten
US3681362A (en) * 1968-06-29 1972-08-01 Shionogi & Co Process for the preparation of isoquinuclidine alkaloids
GB1445287A (en) * 1973-10-24 1976-08-11 Omnium Chimique Sa Derivatives of iboga type alkaloids
FR2296418B1 (de) 1974-12-30 1978-07-21 Anvar
US4499096A (en) * 1983-11-18 1985-02-12 Lotsof Howard S Rapid method for interrupting the narcotic addiction syndrome
US4587243A (en) * 1985-07-15 1986-05-06 Lotsof Howard S Rapid method for interrupting the cocaine and amphetamine abuse syndrome
JPH0341081A (ja) * 1989-07-10 1991-02-21 Mitsui Petrochem Ind Ltd 二量体アルカロイド類の製造方法
US5152994A (en) 1990-05-31 1992-10-06 Lotsof Howard S Rapid method for interrupting or attenuating poly-drug dependency syndromes
JPH0559053A (ja) * 1991-02-28 1993-03-09 Mikio Yamazaki インドールアルカロイド化合物

Also Published As

Publication number Publication date
EP0859610A1 (de) 1998-08-26
DE69635737D1 (de) 2006-04-06
ATE315389T1 (de) 2006-02-15
EP0859610A4 (de) 2002-05-15
WO1997005869A1 (en) 1997-02-20
US6211360B1 (en) 2001-04-03
EP0859610B1 (de) 2006-01-11

Similar Documents

Publication Publication Date Title
IL123220A0 (en) Ibogamine congeners
IL115903A0 (en) Use of dioxomorpholines for combating endoparasites new dioxomorpholines and processes for their preparation
HUP0102471A2 (hu) 4-Benzil-piperidin alkilszulfoxid heterociklusok és használatuk altípus-szelektív NMDA antagonistaként és ezeket tartalmazó gyógyszerkészítmények
TR200001279T2 (tr) Poli (ADP-riboz) polimeraz ("PARP") inhibitörleri, nevral ve kardiyovasküler doku hasarının tedavisi için yöntemler ve farmasötik bileşimler.
FI953838A0 (fi) Imidatsopyriidineja ja niiden käyttö maha-suolisairauksien hoidossa
MY108885A (en) Heterocyclic-cyclic amine derivatives.
MX9203018A (es) Fluoroalcoxibencilamino-derivados de heterociclos nitrogenados.
IL114794A0 (en) Peptidic compounds analogous to distramycin process for their preparation and their use
BG104996A (en) Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation
DE69809754D1 (en) Substituierte 6-phenylphenanthridine
ATE209186T1 (de) Überbrückte azabicyclische derivate als substanz p antagonisten
ATE219765T1 (de) Indolderivate als cgmp-pde inhibitoren
ZA955223B (en) Substituted azaindolylidene compounds and process for their preparation
YU27697A (sh) Sulfonamidi i njihiova upotreba
DK0561941T3 (da) N-Substituerede lactamer anvendelige som cholecystokinin-antagonister
EP1140900A4 (de) Pyrazol verbindungen und ihre verwendung
TW342385B (en) Bicyclic benzazepin, the process for their preparation and the pharmaceutical composition containing them
AU1367497A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma
ES8608503A1 (es) Procedimiento para la fabricacion de nuevos derivados de la cumarina
MX9700959A (es) Derivados de becimidazol que tienen actividad dopaminergica.
IS4367A (is) CCK eða gastrín temprandi 5-heterósýklísk-1,5-bensódíazepín
PL328266A1 (en) Therapeutic compounds
ATE158301T1 (de) 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren
IL104657A0 (en) Benzazepine derivatives,their preparation and pharmaceutical compositions containing them
GB9308431D0 (en) Chemical compounds